• Title/Summary/Keyword: Rubus coreanus $M_{IQ}$.

Search Result 2, Processing Time 0.018 seconds

In vitro Antioxidant Activity of Crude Extract from Rubus coreanus $M_{IQ}$.

  • Shin, Sun-Woo;Yu, Byung-Su;Lee, Jeong-Ho;Baek, Seung-Hwa
    • Journal of Society of Preventive Korean Medicine
    • /
    • v.13 no.1
    • /
    • pp.59-67
    • /
    • 2009
  • Objectives : This research aimed to evaluate the effects of Rubus coreanus $M_{IQ}$. Methods: These extracts from fresh R. coreanus $M_{IQ}$. were investigated with radical scavenging activity, the content of total phenolics, ferric thiocyanate method and flavonoid contents Results: These results revealed that the ethyl acetate extract from fresh R. coreanus $M_{IQ}$. possesses remarkable radical scavenging activity. The content of total phenolics of the ethanol extract from dried R. coreanus $M_{IQ}$. ($IC_{50}$=155.87${\pm}$8.8${\mu}$g/mL) is the highest among all of the samples. The stronger radical-scavenging activity ($IC_{50}$=77.72${\pm}$2.1${\mu}$g/mL) of ethyl acetate extract from dried R. coreanus $M_{IQ}$. should be related to its phenolic content as measured by gallic acid test. Conclusion: These results suggest that dried R. coreanus $M_{IQ}$. may act as a potential antioxidant agent.

  • PDF

Attenuation of airway hyperreactivity (AHR) and inflammation by water extract of Rubus coreanus $M_{IQ.}$ (WRCM) (마우스 천식모델에서 복분자 물추출물의 기도 과민반응 및 염증의 억제 효과)

  • Kim, Kyung-Jun;Lee, Ho-Sub;Jo, Eun-Heui;Park, Min-Cheol
    • The Journal of Korean Medicine Ophthalmology and Otolaryngology and Dermatology
    • /
    • v.20 no.1 s.32
    • /
    • pp.177-194
    • /
    • 2007
  • Fructus of Rubus coreanus $M_{IQ.}$. (FRCM) has been used for stuttering urination, prostate gland disease, and impotence in Korean traditional medicine. Water extract of FRCM (WFRCM) treatment significantly attenuated airway hyperreactivity (AHR). Airway recruitment of leukocytes and eosinophils was also markedly reduced by WFRCM administration, suggesting that WFRCM can alleviate the airway inflammation. However, the level of cytokine (IL-4, IL-5, and IL-13) in bronchoalveolar lavage fluid (BALF) and lung was not different compared with positive control. WFRCM reduced the number of draining lymph node cells during OVA-induced allergic asthma. I further examined transcription level of cytokine in lung. WFRCM treatment reduced IL-4 and IL-13 mRNA in lung and inhibited IgE and IgG1 but not IgG2a. My data suggest that WFRCM attenuates OVA-induced allergic asthma through inhibition of Th2 cell response.

  • PDF